424 related articles for article (PubMed ID: 29175238)
1. Which Patent Foramen Ovales Need Closure to Prevent Cryptogenic Strokes?
Dalen JE; Alpert JS
Am J Med; 2018 Mar; 131(3):222-225. PubMed ID: 29175238
[TBL] [Abstract][Full Text] [Related]
2. Cryptogenic Strokes and Patent Foramen Ovales: What's the Right Treatment?
Dalen JE; Alpert JS
Am J Med; 2016 Nov; 129(11):1159-1162. PubMed ID: 27566504
[TBL] [Abstract][Full Text] [Related]
3. Predictors of recurrent events in patients with cryptogenic stroke and patent foramen ovale within the CLOSURE I (Evaluation of the STARFlex Septal Closure System in Patients With a Stroke and/or Transient Ischemic Attack Due to Presumed Paradoxical Embolism Through a Patent Foramen Ovale) trial.
Elmariah S; Furlan AJ; Reisman M; Burke D; Vardi M; Wimmer NJ; Ling S; Chen X; Kent DM; Massaro J; Mauri L;
JACC Cardiovasc Interv; 2014 Aug; 7(8):913-20. PubMed ID: 25147037
[TBL] [Abstract][Full Text] [Related]
4. Transcatheter Closure of Patent Foramen Ovale versus Medical Therapy after Cryptogenic Stroke: A Meta-Analysis of Randomized Controlled Trials.
Darmoch F; Al-Khadra Y; Soud M; Fanari Z; Alraies MC
Cerebrovasc Dis; 2018; 45(3-4):162-169. PubMed ID: 29597192
[TBL] [Abstract][Full Text] [Related]
5. Advances and Ongoing Controversies in Patent Foramen Ovale Closure and Cryptogenic Stroke.
Gonzalez JB; Testai FD
Neurol Clin; 2021 Feb; 39(1):51-69. PubMed ID: 33223089
[TBL] [Abstract][Full Text] [Related]
6. Percutaneous closure of patent foramen ovale in patients with cryptogenic embolism: a network meta-analysis.
Stortecky S; da Costa BR; Mattle HP; Carroll J; Hornung M; Sievert H; Trelle S; Windecker S; Meier B; Jüni P
Eur Heart J; 2015 Jan; 36(2):120-8. PubMed ID: 25112661
[TBL] [Abstract][Full Text] [Related]
7. Transcatheter Closure of Patent Foramen Ovale: Randomized Trial Update.
Arfaras-Melainis A; Palaiodimos L; Mojadidi MK
Interv Cardiol Clin; 2019 Oct; 8(4):341-356. PubMed ID: 31445719
[TBL] [Abstract][Full Text] [Related]
8. Late complications of transcatheter closure of patent foramen ovale: new technology and new outcomes.
Staubach S; Bertog S; Wunderlich N; Sievert H
Future Cardiol; 2009 Sep; 5(5):503-10. PubMed ID: 19715414
[TBL] [Abstract][Full Text] [Related]
9. Closure of patent foramen ovale or medical therapy alone for secondary prevention of cryptogenic cerebrovascular events.
Fortuni F; Crimi G; Leonardi S; Angelini F; Raisaro A; Lanzarini LF; Oltrona Visconti L; Ferrario M; De Ferrari GM
J Cardiovasc Med (Hagerstown); 2018 Jul; 19(7):373-381. PubMed ID: 29708911
[TBL] [Abstract][Full Text] [Related]
10. Long-term experience and outcomes with transcatheter closure of patent foramen ovale.
Inglessis I; Elmariah S; Rengifo-Moreno PA; Margey R; O'Callaghan C; Cruz-Gonzalez I; Baron S; Mehrotra P; Tan TC; Hung J; Demirjian ZN; Buonanno FS; Ning M; Silverman SB; Cubeddu RJ; Pomerantsev E; Schainfeld RM; Dec GW; Palacios IF
JACC Cardiovasc Interv; 2013 Nov; 6(11):1176-83. PubMed ID: 24262618
[TBL] [Abstract][Full Text] [Related]
11. Patent foramen ovale and cryptogenic stroke: the hole story.
Furlan AJ; Jauss M
Stroke; 2013 Sep; 44(9):2676-8. PubMed ID: 23908069
[TBL] [Abstract][Full Text] [Related]
12. Current Dataset for Patent Foramen Ovale Closure in Cryptogenic Stroke: Randomized Clinical Trials and Observational Studies.
Odunukan OW; Price MJ
Interv Cardiol Clin; 2017 Oct; 6(4):525-538. PubMed ID: 28886843
[TBL] [Abstract][Full Text] [Related]
13. Transcatheter closure versus medical therapy of patent foramen ovale and presumed paradoxical thromboemboli: a systematic review.
Khairy P; O'Donnell CP; Landzberg MJ
Ann Intern Med; 2003 Nov; 139(9):753-60. PubMed ID: 14597460
[TBL] [Abstract][Full Text] [Related]
14. A Review of Transcatheter Closure of Patent Foramen Ovale.
Neill J; Lin CH
Methodist Debakey Cardiovasc J; 2017; 13(3):152-159. PubMed ID: 29744000
[TBL] [Abstract][Full Text] [Related]
15. Propensity Score-Based Analysis of Percutaneous Closure Versus Medical Therapy in Patients With Cryptogenic Stroke and Patent Foramen Ovale: The IPSYS Registry (Italian Project on Stroke in Young Adults).
Pezzini A; Grassi M; Lodigiani C; Patella R; Gandolfo C; Zini A; DeLodovici ML; Paciaroni M; Del Sette M; Toriello A; Musolino R; Calabrò RS; Bovi P; Adami A; Silvestrelli G; Sessa M; Cavallini A; Marcheselli S; Marco Bonifati D; Checcarelli N; Tancredi L; Chiti A; Del Zotto E; Tomelleri G; Spalloni A; Giorli E; Costa P; Giacalone G; Ferrazzi P; Poli L; Morotti A; Piras V; Rasura M; Simone AM; Gamba M; Cerrato P; Zedde ML; Micieli G; Melis M; Massucco D; Guido D; De Giuli V; Bonaiti S; D'Amore C; La Starza S; Iacoviello L; Padovani A;
Circ Cardiovasc Interv; 2016 Sep; 9(9):. PubMed ID: 27582111
[TBL] [Abstract][Full Text] [Related]
16. Closure or medical therapy for cryptogenic stroke with patent foramen ovale.
Furlan AJ; Reisman M; Massaro J; Mauri L; Adams H; Albers GW; Felberg R; Herrmann H; Kar S; Landzberg M; Raizner A; Wechsler L;
N Engl J Med; 2012 Mar; 366(11):991-9. PubMed ID: 22417252
[TBL] [Abstract][Full Text] [Related]
17. The Case for Selective Patent Foramen Ovale Closure After Cryptogenic Stroke.
Wiktor DM; Carroll JD
Circ Cardiovasc Interv; 2018 Mar; 11(3):e004152. PubMed ID: 29870380
[TBL] [Abstract][Full Text] [Related]
18. Role of closure of patent foramen ovale in cryptogenic stroke: Current status.
Abhishek BS; Bhambhani A
Natl Med J India; 2017; 30(5):268-271. PubMed ID: 29916427
[TBL] [Abstract][Full Text] [Related]
19. Patent foramen ovale and cryptogenic stroke in older patients.
Handke M; Harloff A; Olschewski M; Hetzel A; Geibel A
N Engl J Med; 2007 Nov; 357(22):2262-8. PubMed ID: 18046029
[TBL] [Abstract][Full Text] [Related]
20. Device Closure of Patent Foramen Ovale for Cryptogenic Stroke: Patient Selection and Outcomes According to New Randomized Trials.
Carroll AM; Carroll JD
Curr Cardiol Rep; 2019 Apr; 21(6):48. PubMed ID: 31011896
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
